You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP887 A synergistic anticancer effect of combination treatment with a cell cycle checkpoint kinase 1 inhibitor and PARP inhibitor in BRCA wild type epithelial ovarian cancer

Article metrics

Article menu
Download PDFPDF
ePoster
EP887 A synergistic anticancer effect of combination treatment with a cell cycle checkpoint kinase 1 inhibitor and PARP inhibitor in BRCA wild type epithelial ovarian cancer

 

Online download statistics by month:

Online download statistics by month: November 2019 to October 2024

AbstractFullPdf
Nov 20191201
Jan 2020400
Feb 20201200
Mar 2020700
Apr 20203503
May 20201700
Jun 20201800
Jul 20202200
Aug 20201500
Sep 20202500
Oct 20202600
Nov 20202802
Dec 20202600
Jan 20211601
Feb 2021400
Mar 2021800
Apr 2021600
May 2021700
Jun 2021200
Oct 2021800
Nov 20211001
Dec 2021800
Jan 20221000
Feb 20221400
Mar 20221100
Apr 2022700
May 20221200
Jun 2022600
Jul 20221000
Aug 2022600
Sep 2022600
Oct 2022600
Nov 20221000
Dec 20221000
Jan 2023600
Feb 20231200
Mar 2023800
Apr 2023400
May 2023400
Jun 2023400
Jul 2023400
Aug 2023601
Sep 2023400
Oct 2023200
Nov 20231000
Dec 20231400
Jan 20242800
Feb 2024400
Mar 2024800
Apr 20241900
May 2024800
Jun 20241600
Aug 2024200
Sep 20241200
Oct 2024400
Total60309